Transforming growth factor β 1 potently activates CPP32-like proteases in human hepatoma cells

Cellular Signalling

Volumn 10, Issue 7, 1998, Pages 511-515

  Hung, Wen Chun ^a   Chang, Hui Chiu ^a   Chuang, Lea Yea ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Apoptosis; Caspase; CPP32; Interleukin 1 converting enzyme; Transforming growth factor 1

Indexed keywords

INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 1BETA CONVERTING ENZYME INHIBITOR; PROTEINASE; TRANSFORMING GROWTH FACTOR BETA1;

APOPTOSIS; ARTICLE; ENZYME ACTIVATION; HEPATOMA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

AMINO ACID CHLOROMETHYL KETONES; APOPTOSIS; CASPASE 3; CASPASES; CYSTEINE PROTEINASE INHIBITORS; ENZYME ACTIVATION; HUMANS; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0031694758     PISSN: 08986568     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0898-6568(97)00189-7     Document Type: Article

References (32)

1. Ellis R. E., Yuan J. and Horvitz H. R. (1991) Annu. Rev. Cell Biol. 7, 663-698.
2. Earnshaw W. C. (1995) Curr. Opin. Cell Biol. 7, 337-343.
3. Earnshaw W. C. (1995) Trends Cell Biol. 5, 217-220.
4. Thompson C. B. (1995) Science 267, 1456-1462.
5. Kingsley D. M. (1994) Genes Dev. 8, 133-146.
6. Massaque J., Attisano L. and Wrana J. L. (1994) Trends Cell Biol. 4, 172-177.
7. Moses H. L., Yang E. Y. and Pietenpol J. A. (1990) Cell 63, 245-247.
8. Lyons R. M. and Moses H. L. (1990) Eur. J. Bochem. 187, 467-473.
9. Geng Y. and Weinberg R. A. (1993) Proc. Natl. Acad. Sci. USA 90, 10315-10319.
10. Polyak K., Kato J. Y., Solomon M. J., Sherr C. J., Massaque J., Robert J. M. and Koff A. (1994) Genes Dev. 8, 9-22.
11. Hannon G. J. and Beach D. (1994) Nature 371, 257-260.
12. Fausto N. (1993) Hepatology 18, 1536-1537.
13. Oberhammer F. A., Pavelka M., Sharma S., Tiefenbacher R., Purchio A. F., Bursch W. and Schulte-Herman R. (1992) Proc. Natl. Acad. Sci. USA 89, 5408-5412.
14. Fukuda K., Kojiro M. and Chiu J. F. (1993) Hepatology 18, 945-952.
15. Lin J. K. and Chou C. K. (1992) Cancer Res. 52, 385-388.
16. Chuang L. Y., Hung W. C., Chang C. C. and Tsai J. H. (1994) Anticancer Res. 14, 147-152.
17. Martin S. J. and Green D. R. (1995) Cell 82, 349-352.
18. Miura M., Zhu H., Rotello R., Hartweig E. A. and Yuan J. (1993) Cell 75, 653-660.
19. Yuan J., Shaham S., Ledoux S., Ellis H. M. and Horvitz H. R. (1993) Cell 75, 641-652.
20. Hung W. C. and Chuang L. Y. (1996) Biochem. Biophys. Res. Commun. 229, 11-15.
21. Patel T., Gores G. J. and Kaufmann S. H. (1996) FASEB J. 10, 587-597.
22. Faleiro L., Kobayashi R., Fearnhead H. and Lazebnik Y. (1997) EMBO J. 16, 2271-2281.
23. Margolin N., Raybuck S. A., Wilson K. K., Chen W., Fox T., Gu Y. and Livingston D. J. (1997) J. Biol. Chem. 272, 7223-7228.
24. Fernandes-Alnemr T., Litwack G. and Alnemri E. S. (1994) J. Biol. Chem. 269, 30761-30764.
25. Tewari M., Quan L. T., O'Rourke K., Desnoyers S., Zeng Z., Beidler D. R., Poirier C. G., Salvesen G. S. and Dixit V. M. (1995) Cell 81, 801-809.
26. Caciola-Rosen L. A., Nicholson D. W., Chong K. R., Rowan K. R., Thornberry N. A., Miller D. K. and Rosen A. (1996) J. Exp. Med. 183, 1957-1964.
27. Inayat-Hussain S. H., Couet C., Cohen G. M. and Cain K. (1997) Hepatology 25, 1516-1526.
28. Enari M., Talanian R. V., Wong W. W. and Nagata S. (1996) Nature 380, 723-726.
29. Chinnaiyan A. M. and Dixit V. M. (1996) Curr. Biol. 6, 555-562.
30. Krajewska M., Wang H. G., Krajewski J. M., Shabaik A., Gascoyne R. and Reed. J. C. (1997) Cancer Res. 57, 1605-1613.
31. Fynn T. M. and Reiss M. (1993) Crit. Rev. Oncol. 4, 493-540.
32. Massaque J. (1996) Cell 85, 947-950.